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The experiences of frontline healthcare professionals are essential in identifying strategies
to mitigate the disruption to healthcare services caused by the COVID-19 pandemic.
Methods
We conducted a cross-sectional study of TB and HIV professionals in low and middle-
income countries (LMIC). Between May 12 and August 6, 2020, we collected qualitative and
quantitative data using an online survey in 11 languages. We used descriptive statistics and
thematic analysis to analyse responses.
Findings
669 respondents from 64 countries completed the survey. Over 40% stated that it was either
impossible or much harder for TB and HIV patients to reach healthcare facilities since
COVID-19. The most common barriers reported to affect patients were: fear of getting
infected with SARS-CoV-2, transport disruptions and movement restrictions. 37% and 28%
of responses about TB and HIV stated that healthcare provider access to facilities was also
severely impacted. Strategies to address reduced transport needs and costs–including pro-
active coordination between the health and transport sector and cards that facilitate lower
cost or easier travel—were presented in qualitative responses. Access to non-medical sup-
port for patients, such as food supplementation or counselling, was severely disrupted
according to 36% and 31% of HIV and TB respondents respectively; qualitative data sug-
gested that the need for such services was exacerbated.
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Conclusion
Patients and healthcare providers across numerous LMIC faced substantial challenges in
accessing healthcare facilities, and non-medical support for patients was particularly
impacted. Synthesising recommendations of frontline professionals should be prioritised for
informing policymakers and healthcare service delivery organisations.
Introduction
The direct health effects of the COVID-19 pandemic are colossal, and are continuing to grow,
with approximately one million deaths directly attributed to COVID-19 [1]. However,
researchers and practitioners have already highlighted that the indirect effects of COVID-19
on global health—through the disruption of essential healthcare services—may be even larger
and longer lasting [2, 3].
TB and HIV are the two infectious diseases that cause the highest number of deaths glob-
ally; in 2018, 1.5 and 1.1 million people died from TB and from HIV-related illnesses respec-
tively [4, 5]. National programmes for controlling these diseases already face immense
challenges, and the pandemic has increased these by diverting healthcare professionals and
resources to contain COVID-19 [6, 7]. Evidence from the Ebola crisis provides a warning of
the reversals in progress that accompany a pandemic; for example, significant decreases in
diagnoses of smear-positive TB, HIV testing and antiretroviral therapy uptake in Liberia have
been documented [8]. A modelling study estimating the impact of severe disruptions to service
delivery predicted that HIV and TB deaths could increase by up to 10% and 20% over five
years respectively in high-burden settings, reverting to levels seen a decade ago [9].
Policies to minimise disruptions to TB and HIV care must be put in place urgently. To do
this, we need to understand the range of impacts of COVID-19 on TB and HIV services, and
identify feasible strategies for mitigation. Information from frontline health professionals and
researchers is invaluable and often insufficiently incorporated into policy planning or in the
formation of research questions [10, 11]. In light of this, our study rapidly synthesised infor-
mation from professionals working in affected countries, in order to identify both how
COVID-19 is impacting TB and HIV services in LMIC and their recommendations for mini-
mising disruptions.
Methods
We analysed quantitative and qualitative data collected through a rapid cross-sectional survey
of TB and HIV healthcare delivery, management and research professionals in LMIC around
the world.
Study design, population and sampling
Our open online survey was conducted between May 12 and August 6 2020. The methodology
was designed based on a standardised checklist for internet surveys (CHERRIES) [12]. Our
target population was individuals who were involved in managing or delivering TB or HIV
services, including, but not limited to: doctors, nurses, community healthcare providers, labo-
ratory technicians, policymakers, health facility managers, representatives of charity, commu-
nity or advocacy groups, and researchers.
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We used three approaches to share the invitation to complete our survey. First, we sent
information through online professional platforms and personal networks with colleagues
(using email, WhatsApp or Twitter). Second, we hired one focal point for Asia, one for Latin
America, and one for Africa. Focal points focused on contacting local organisations in their
regions. Third, we used snowball sampling, whereby survey participants were asked to share
the survey with others who might have information to contribute. Through these approaches,
the survey was shared with over 250 professional networks and organisations.
Survey
The survey was initially designed in English by an international team with diverse expertise in
TB and HIV control working in Europe, Asia and Africa. It was first piloted with eight profes-
sionals working in Cambodia, The Gambia, South Africa, The Philippines, Pakistan, Zambia
and Zimbabwe; this allowed us to check face validity and refine the wording of questions and
response options. Following this, we piloted an electronic version (in SurveyMonkey) with five
public health professionals to check the accessibility and functionality of the survey as it
appeared on the online platform.
Using SurveyMonkey enabled us to administer a survey that could only be answered once
per device, and did not collect identifying information. We provided introductory text and a
downloadable information sheet on the landing page. Respondents gave consent—after read-
ing the information sheet—by checking boxes to confirm that they agreed to participate and
allowed text responses to be quoted verbatim. It was possible for participants to agree to partic-
ipate, but to decline use of verbatim quotes.
We used adaptive questioning, whereby nine HIV or TB- specific questions, or 18 covering
both, were displayed based depending on which areas the respondent wanted to provide infor-
mation about. Of the nine questions, seven were multiple choice (Table 2), with space to add
free text using the ‘other’ option. There were two open response questions that only collected
free text and these constitute the qualitative responses. The first asked about COVID-19 related
rules that have been introduced by the government and how these have impacted TB/HIV
health services. The second solicited information about measures that can be taken (or have
already been taken) to minimize disruptions. There was no limit to the amount of text a
respondent could insert.
The survey and participant information sheet were translated into 10 additional languages:
Arabic, Bahasa, Chinese, French, Portuguese, Russian, Shona, Spanish, Swahili, and Urdu.
There were at least two translators for each language, so that every translation was checked by
an independent native or fluent speaker.
Data management and analysis
All data was downloaded into MS Excel. The quantitative data was analysed using descriptive
statistics (frequencies and percentages) in Stata/SE V.14 (StatCorp, Texas, USA).
Our qualitative analysis involved translating non-English language text into English, and
conducting a thematic analysis. We used an interpretive approach in which identified themes
were supported by the data. The thematic analysis process began by two authors agreeing on
the emerging themes after reading the text responses independently and then coding the text
line by line manually. Finally, we triangulated qualitative and quantitative results to validate
findings.
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Ethical approval
We received ethical approval from the London School of Hygiene and Tropical Medicine, the
University of Zambia and The South African Medical Association.
Results
Of the 923 respondents that initiated the consent process and accessed survey questions, 669
(72%) from 64 countries completed it. 567 respondents answered the TB section, and 346
answered the HIV section. There was a greater representation of health professional based in
sub-Saharan African countries in responses about HIV as compared to TB (Fig 1). Demo-
graphic and professional characteristics of respondents are in Table 1. We compared answers
provided by respondents in different professional categories and did not find substantial
variation.
Access to healthcare facilities for patients and providers
Our survey indicated that access to healthcare facilities for TB and HIV healthcare providers
and patients has been substantially affected (Table 2). Over 40% of respondents stated that it
was impossible or much harder for TB and HIV patients to reach healthcare facilities since
COVID-19. Similarly, it was much harder or impossible for TB healthcare providers to reach
their place of work since COVID-19 began, according to 37% of respondents. Challenges were
also reported in relation to HIV healthcare providers reaching their place of work, but these
were not considered as severe as for HIV patients.
Concerns and barriers for TB and HIV patients to access healthcare were similar. The fol-
lowing were identified by more than 50% of respondents: fear of getting infected with SARS-
CoV-2, transport disruptions, movement restrictions owing to lockdowns and reduced
income. Disruption to transport services was a recurring theme in the qualitative data, men-
tioned over 30 times across Asian, African and Latin American countries. Specifically, it was
highlighted that both reduced access to usual modes of transport and increased cost of trans-
port created barriers to reaching healthcare facilities for both healthcare providers and
patients. Furthermore, the impact of transport disruptions on essential supplies reaching
healthcare facilities was noted repeatedly as an issue to address: Monitor the lockdown enforce-
ment to make sure it really doesn't hamper movement of essential items; other endemic diseases
should not be neglected due to COVID-19. [M, doctor, Nigeria]. Three policies to address trans-
port disruptions suggested were: proactive coordination between the health and transport sec-
tor (including private transport companies); cards that facilitate lower cost or easier travel for
patients and providers, and public information to reassure patients that they can travel for
healthcare.
Alternative solutions, suggested by over 40 respondents, focused on ways to reduce the
need for patients to travel to healthcare facilities. These solutions relied on bringing services
closer to patients’ homes, and providing medication for longer durations. As an adaptation to
COVID-19 situation, it was commonly reported that medicines for TB and HIV were allowed
to be given for several months at one time; some responses indicated challenges in doing this
due to insufficient supplies. Provision of HIV and TB medicines to cover longer periods, how-
ever, does not address the need for patients to interact with healthcare providers as part of
treatment monitoring and follow-up support. Telemedicine was identified as a solution by
more than 50 respondents. This was reported to be operating in some facilities in countries
such as Argentina and South Africa, and was proposed as a way of providing better services in
the future, even outside of a health emergency. Antiretrovirals are handed out at home to avoid
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patient exposure. . .a telephone line was implemented for access to consul1tations through tele-
medicine. [F, manager of health facility, Argentina]
Recommendations to bring healthcare closer to communities included delivery of counsel-
ling and medicines through community volunteers or local private providers, and setting up
Fig 1. Geographical distribution of survey respondents.
https://doi.org/10.1371/journal.pone.0244936.g001
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community collection points. Numerous respondents encouraged flexibility in where patients
are allowed to collect medicines, since some patients may relocate to their villages from urban
areas when employment opportunities are affected.
Disruptions to service provision at TB and HIV facilities
Over 70% of respondents reported that TB and HIV facilities had revised their operating pro-
cedures to include physical distancing protocols for patients, and over 70% also reported that
TB and HIV facilities had introduced Personal Protective Equipment (PPE) for healthcare pro-
viders. The importance of PPE, and masks in particular, was mentioned commonly (35 times
for healthcare providers and 20 times for patients) across numerous countries. We noted a dif-
ference in whether respondents stressed the need for masks specifically for doctors, or for
other providers such as laboratory technicians and community healthcare workers. We also
found that some doctors and healthcare managers emphasised the need for education on infec-
tion prevention practices in conjunction with increased access to masks. Concerns were raised
about a lack of clarity on who should be responsible for providing PPE, and the cost burden on
poorer patients if they are required to source their own masks: Most TB patients are poor. They
cannot afford masks and sanitizer [F, researcher, Pakistan]
Table 1. Respondents’ characteristics.
Variables TB (n = 567) N (%) HIV (n = 346) N (%)
Age (years) 18–24 13 (2.3) 5 (1.5)
25–34 160 (28.2) 105 (30.4)
35–44 181 (31.9) 118 (34.1)
45–54 128 (22.6) 68 (19.7)
55–64 70 (12.3) 41 (11.9)
65+ 14 (2.5) 9 (2.6)
Prefer not to answer 1 (0.2) 0
Gender Female 302 (53.3) 168 (48.6)
Male 257 (45.3) 176 (50.9)
Prefer not to answer 8 (1.4) 2 (0.6)
Role Doctor providing care to patients 154 (27.2) 129 (37.3)
Nurse providing patient care 44 (7.8) 25 (7.2)
Community healthcare worker 45 (7.9) 16 (4.6)
Other health care provider 47 (8.3) 28 (8.1)
Researcher 96 (16.9) 48 (13.9)
Manager of health care facility or programme 137 (24.2) 70 (20.2)
Laboratory scientist 14 (2.5) 2 (0.6)
Public health specialist 14 (2.5) 5 (1.5)
Other 16 (2.8) 23 (6.6)
Organisation Public sector healthcare facility 194 (34.2) 122 (35.3)
International non-governmental organisation 93 (16.4) 60 (17.3)
Government agency 60 (10.6) 24 (6.9)
University or academic body 57 (10.1) 41 (11.9)
Private, for-profit healthcare facility 54 (9.5) 28 (8.1)
Charity/non-profit healthcare facility 52 (9.2) 29 (8.4)
Domestic non-governmental organisation 47 (8.3) 36 (10.4)
Funding agency 6 (1.1) 3 (0.9)
Other 4 (0.7) 3 (0.9)
https://doi.org/10.1371/journal.pone.0244936.t001
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Only 16% and 11% of HIV and TB respondents reported that standard medical treatment
was very difficult or impossible to provide. In contrast, we found that access to non-medical
support for patients, such as food supplementation (where available) or counselling, was much
Table 2. Quantitative survey findings.
Questions TB (n = 567) N
(%)
HIV (n = 346) N
(%)
Has it been harder for healthcare providers to come to work at healthcare facilities
since COVID-19?
No- same as before 98 (17.3) 61 (17.6)
Yes—it is slightly harder 245 (43.2) 182 (52.6)
Yes—it is much harder 179 (31.6) 85 (24.6)
Yes—it is very difficult or impossible 28 (4.9) 13 (3.8)
Don’t know 14 (2.5) 4 (1.2)
Prefer not to answer 3 (0.5) 1 (0.3)
Has it been harder for patients to come seek care at healthcare facilities since
COVID-19?
No- same as before 56 (9.9) 37 (10.7)
Yes—it is slightly harder 266 (46.9) 159 (46.0)
Yes—it is much harder 193 (34.0) 120 (34.7)
Yes–it is very difficult or impossible 40 (7.1) 24 (6.9)
Don’t know 8 (1.4) 5 (1.5)
Prefer not to answer 4 (0.7) 1 (0.3)
What do you think are the main concerns or barriers for patients to access healthcare
since COVID-19
Fear of getting infected with SARS-CoV-2 422 (74.4) 247 (71.4)
Transport disruption 395 (69.7) 270 (78.0)
Lockdown 388 (68.4) 207 (59.8)
Reduced income/ money to travel 293 (51.7) 260 (75.1)
Clinical closures 142 (25.0) 97 (28.0)
Health care workers shortage 131 (23.1) 102 (29.5)
Unable to access a face mask 123 (21.7) 68 (19.7)
Long waiting times 91 (16.0) 80 (23.1)
There are no concerns 48 (8.5) 29 (8.4)
Since COVID-19, are you aware of any changes to the way healthcare facilities are
operating?
Physical distancing protocols for patients 420 (74.1) 272 (78.6)
Masks or other protective equipment for
healthcare providers
399 (70.4) 255 (73.7)
Prefer not to answer 22 (3.9) 12 (3.5)
Have you experienced shortages of diagnostics or other challenges to provision of
routine diagnostic services since COVID-19?
No- same as before 168 (29.6) 120 (34.7)
Yes—it is slightly harder 193 (34.0) 124 (35.8)
Yes—it is much harder 139 (24.5) 63 (18.2)
Yes–it is very difficult or impossible 23 (4.1) 19 (5.5)
Don’t know 36 (6.3) 16 (4.6)
Prefer not to answer 8 (1.4) 4 (1.2)
Have you experienced shortages of medicines or other challenges to provision of
standard treatment since COVID-19?
No- same as before 300 (52.9) 159 (46.0)
Yes—it is slightly harder 150 (26.5) 113 (32.7)
Yes—it is much harder 58 (10.2) 43 (12.4)
Yes–it is very difficult or impossible 7 (1.2) 13 (3.8)
Don’t know 41 (7.2) 16 (4.6)
Prefer not to answer 11 (1.9) 2 (0.6)
Has it been harder for patients to access non-medical support such as food
supplementation or counselling since COVID-19?
No- same as before 103 (18.2) 60 (17.3)
Yes—it is slightly harder 223 (39.3) 122 (35.3)
Yes—it is much harder 137 (24.1) 97 (28.0)
Yes–it is very difficult or impossible 38 (6.7) 27 (7.8)
Don’t know 19 (3.4) 13 (3.8)
Prefer not to answer 47 (8.3) 27 (7.8)
https://doi.org/10.1371/journal.pone.0244936.t002
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harder or impossible to access according to 36% and 31% of respondents that answered ques-
tions about HIV and TB respectively. Less than 20% said that these important services were
unchanged. Furthermore, the qualitative data suggested that nutritional support became par-
ticularly critical when movement restrictions and employment instability further reduced
access to income and food. A repeated suggestion was that food supplementation should be
paired with community-based delivery of drug supplies: Poor patients also miss the nutrition
they used to receive at the TB facilities. Provide nutrition with the drug supplies [M, health facil-
ity manager, Somalia]
While many respondents advocated for the upkeep of counselling services for patients, the
need for mental health support for providers was not mentioned. Increased workload and
stress was mentioned as a problem, but few provided solutions. The solutions mentioned
included financial incentives to compensate for the increased occupational risk and hiring of
additional healthcare providers to account for the greater work load. Shift working systems
were also suggested to reduce the number of healthcare providers in facilities at any given
time, especially in space-limited settings such as laboratories.
Impacts on supply chains and diagnostic services
There were mixed views on challenges around the provision of routine diagnostic services for
TB and HIV, indicating that the experiences of respondents varied considerably. Approxi-
mately one third reported that providing diagnostic services had been slightly harder and a
similar proportion reported no change since COVID-19, while 29% and 24% reported that TB
and HIV diagnostic services were very hard or impossible to provide. Qualitative data indi-
cated that countries with more centralised production or storage of essential supplies might
face greater challenges in maintaining supply chains for diagnostics due to greater reliance on
transport. Similarly, where diagnostics were not produced domestically, risk of disruptions
increased, according to the qualitative data. Suggested solutions included shifting to quality-
assured local production and decentralisation of diagnostics wherever possible.
Stigma
Qualitative responses highlighted concerns about increased stigmatisation of HIV and TB
patients owing to changes in the delivery of health services. Examples provided by respondents
included stigmatisation when HIV patients were asked to show health cards in order to travel,
when patients presenting with TB symptoms were first isolated and tested for COVID-19, and
when attention is drawn to HIV or TB patients in their neighbourhoods during community-
based distribution of medicines.
(It is) difficult to ask people living with HIV to show their medical records at road blocks as
this discloses their status. [F, doctor, Zimbabwe]
To develop a strategy for the supply of medication at a community level, being supplied
together with other types of assistance to protect the identity of those wishing for health status
anonymity. [F, community healthcare worker, Dominican Republic]
Another strong theme was fear and stigma of COVID-19. It was frequently reported that
people were worried that healthcare providers or community members would think they had
COVID-19 if they sought care for TB. This was identified as a priority area to be addressed:
Need to reduce stigma about COVID-19 and associations with TB. [M, manager, Kenya]
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Discussion
Our multi-country survey provides current evidence of the widespread impacts of COVID-19
on TB and HIV patients, healthcare providers and delivery of routine services. It also identifies
specific policies and service delivery adaptations that can be implemented to mitigate disrup-
tions (Table 3). We summarise three key disruptions and their implications. First, we found
that disruptions to transport services posed substantial challenges not only to patients, but also
to healthcare providers. Second, our data indicated that addressing transport challenges alone
would not be sufficient, owing to the barrier posed by patients’ fears of contracting SARS-
CoV-2. Third, in terms of disruption to service provision, the reduction in patient access to
critical non-medical support was striking. Less than 20% of respondents stated that access to
non-medical support was unaffected. As suggested by our qualitative data and other studies
[13–15], mitigating disruptions to provision of food supplementation and mental health sup-
port is critical due to the increased stress, unemployment and loss of income caused by health
emergencies.
Frontline professionals identified important solutions to minimise disruptions from health
emergencies. Health service adaptations to reduce the need for long journeys to healthcare
facilities, included: community-based kiosks to enable collection of medication, telemedicine
services and telephone helplines. Some of these were proposed as sustainable improvements
for healthcare delivery that could be adopted even outside of emergency situations. Practical
Table 3. Recommendations to minimise disruptions to TB and HIV programmes from COVID-19.
Address physical barriers to health facility
access
• Health and transport departments must proactively collaborate to
implement transport schemes (i.e., provision of transport subsidies
or private transport) to ensure that healthcare providers and
patients can access health facilities during the COVID-19 pandemic.
Any special transport schemes for patients must place patients’
rights to privacy at their core.
• Launch communication campaigns to share information about
permitted travel to health facilities during lockdowns, transport
schemes available to healthcare providers and patients, and
procedures in place to reduce the risks of COVID-19 transmission
during travel and at health facilities.
Reduce the need for in-person health facility
visits
• Uninterrupted drug supply can be achieved by providing
medication for longer durations (decreasing the need for re-fills)
and/or bringing services closer to the patient through establishing
community medicine collection points or delivering medicines to
patients’ homes.
• Implement telemedicine systems for follow-ups and consultations
that do not require physical examination–particularly for patients
already established on HIV and/or TB treatment.
Ensure the continuation of non-medical
support services and address stigma
• Maintain and expand nutritional and mental health support
services. Nutritional and mental health services should be brought
closer to communities and, when possible, integrated with medical
services to limit the necessity of multiple trips.
• COVID-19 must not be allowed to increase stigmatisation of HIV
and TB patients owing to changes in the delivery of health services.
This includes stigmatisation when patients must show health cards
in order to travel or when patients presenting with TB symptoms
are first isolated and tested for COVID-19.
Support healthcare providers • Provide easily available counselling and other mental health
services for healthcare providers who are experiencing increased
workloads and stress during the pandemic. Consider the use of
financial and non-financial incentives, such as improved working
conditions, to motivate healthcare workers and recognise their
personal sacrifices and commitment.
https://doi.org/10.1371/journal.pone.0244936.t003
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strategies to address barriers to using transport services for accessing healthcare and to
improve healthcare provider motivation and safety were also identified.
Researchers have concluded that health system resilience entails a combination of absorp-
tive, adaptive and transformative strategies [16]. For example, overcrowding of urban health
can at least partly be overcome by community-based care and telemedicine. However, the con-
sequences of ongoing adaptations on health outcomes and the impacts of changes in service
delivery on stigma and equity must be constantly examined. For example, home delivery of
medications may impact the former, while reliance on access to a phone for telemedicine ser-
vices may impact the latter.
Complex health systems consist of both hardware(infrastructure, commodities, human
resources and finances) and software (knowledge, values, norms, and feelings that shape health
service delivery) [17]. Our study indicated that the software of health systems, such as mental
health and motivation of healthcare workers, both of which are known to be affected in out-
break situations, was being neglected by current responses to COVID-19 [18].
Finally, our study demonstrates that frontline professional in LMICs have invaluable expe-
rience, and that sharing information between organisations in the same country and across
LMIC should be facilitated. Solutions applied in one country could be adapted for use in
another LMIC, and may be more appropriate than policies designed by decision makers who
are less embedded in the realities of LMIC health services [19–21].
Although there are important strengths of our survey-based study, such as rapid gathering
of data in low technology settings, and the wide array of countries we received data from, we
acknowledge that bias can result from 1) the non-representative nature of the population sam-
pled and 2) the self-selection of participants. Though the survey was available in 11 languages,
we missed professionals who speak other languages and we were informed by colleagues in
some countries (Russia and China) that participants did not feel comfortable responding to
such a survey. We also received more responses about TB than HIV.
Conclusions
Data from this first multi-country survey focusing on experiences of frontline professionals
showed that challenges to accessing healthcare facilities and maintaining routine service deliv-
ery–particularly in relation to diagnostics and non-medical support—were substantial across
LMIC following COVID-19. Frontline professionals identified important mitigation strategies,
including adaptations to reduce the costs or need for patients and providers to travel to health-
care facilities, measures to address healthcare provider safety and motivation, and approaches
to tackle increases in stigma. These professionals, who are deeply involved in delivering, man-
aging or analysing service delivery during emergencies such as COVID-19, will not have the
time or connections to influence planning of policies, despite having insights that are critical
for effective policy setting. Rapid synthesis of information them can facilitate identification of
service delivery barriers and bottlenecks presenting during emergency situations, and help
develop effective adaptations. Furthermore, some of the emerging changes to healthcare deliv-
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21. Büyüm AM, Kenney C, Koris A, Mkumba L, Raveendran Y. Decolonising global health: if not now,
when? BMJ Global Health. 2020; 5(8):e003394. https://doi.org/10.1136/bmjgh-2020-003394 PMID:
32759186
PLOS ONE Mitigating the impact of COVID-19 on tuberculosis and HIV services in low and middle-income countries
PLOS ONE | https://doi.org/10.1371/journal.pone.0244936 February 2, 2021 12 / 12
